The COVID-19 vaccine that was dreamed up and developed by Massachusetts-based Moderna will also be manufactured in the state.
Said Moderna co-founder Noubar Afeyan: “I don’t know where else you can do that. You might be able to do that in little pockets here and there. But Boston, Massachusetts is, I would argue, the only place where this could have been developed.”
Moderna, an MLSC Tax Incentive portfolio company, built a 200,000 sq. ft. manufacturing plant in Norwood, Massachusetts to advance its vast pipeline of mRNA medicines. This expansion of a Cambridge-based company diversifying its job creation efforts outside Boston/Cambridge represents the exact type of growth the MLSC looks to support through Tax Incentives.